Novo Nordisk
Jul 11, 2026, 21:43
Sharing New Research in Hemophilia at ISTH 2026 – Novo Nordisk Medical US
Novo Nordisk Medical US shared a post on X:
“Heading to ISTH 2026 in Paris?
We look forward to sharing new research in hemophilia at the congress.
Here is a snapshot of our oral presentations. Feel free to stop by booth 907 to engage with the Novo Nordisk medical team.
Visit the ISTH congress program for more details.”
Proceed to the video attached to the post.
Stay Updated with ISTH 2026 on Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients